The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
6-(2-(1-(6-methylpyridazin-3-yl)piperidin-4-yl)ethoxy)-3-propoxybenzo[d]isoxazole ID: ALA2062891
PubChem CID: 504460
Max Phase: Preclinical
Molecular Formula: C22H28N4O3
Molecular Weight: 396.49
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCCOc1noc2cc(OCCC3CCN(c4ccc(C)nn4)CC3)ccc12
Standard InChI: InChI=1S/C22H28N4O3/c1-3-13-28-22-19-6-5-18(15-20(19)29-25-22)27-14-10-17-8-11-26(12-9-17)21-7-4-16(2)23-24-21/h4-7,15,17H,3,8-14H2,1-2H3
Standard InChI Key: MOLSIBMDDPYHTL-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
-4.2539 -5.3664 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.4306 -5.3676 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.0177 -4.6557 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.4311 -3.9423 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.2575 -3.9451 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.6626 -4.6575 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.4876 -4.6599 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1927 -4.6559 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.7841 -5.3734 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9626 -5.3754 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5440 -4.6623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9572 -3.9454 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7849 -3.9415 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2810 -4.6656 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6943 -3.9522 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5194 -3.9555 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.9311 -4.6722 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5135 -5.3824 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9245 -6.0986 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7543 -4.6707 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1636 -5.3839 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7507 -6.1004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3007 -6.7174 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0576 -6.3796 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.9728 -5.5565 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.8779 -7.4255 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.0530 -7.4116 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6263 -8.1155 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8014 -8.1016 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11 14 1 0
6 7 1 0
14 15 1 0
3 4 2 0
15 16 1 0
3 8 1 0
16 17 1 0
8 9 1 0
17 18 2 0
18 19 1 0
19 22 2 0
4 5 1 0
21 20 2 0
20 17 1 0
21 22 1 0
2 3 1 0
5 6 2 0
6 1 1 0
8 13 1 0
9 10 1 0
22 23 1 0
23 24 2 0
24 25 1 0
25 21 1 0
10 11 1 0
23 26 1 0
11 12 1 0
26 27 1 0
12 13 1 0
27 28 1 0
1 2 2 0
28 29 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 396.49Molecular Weight (Monoisotopic): 396.2161AlogP: 4.40#Rotatable Bonds: 8Polar Surface Area: 73.51Molecular Species: NEUTRALHBA: 7HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 4.41CX LogP: 3.79CX LogD: 3.79Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.56Np Likeness Score: -1.50
References 1. Feil SC, Hamilton S, Krippner GY, Lin B, Luttick A, McConnell DB, Nearn R, Parker MW, Ryan J, Stanislawski PC, Tucker SP, Watson KG, Morton CJ.. (2012) An Orally Available 3-Ethoxybenzisoxazole Capsid Binder with Clinical Activity against Human Rhinovirus., 3 (4): [PMID:24900468 ] [10.1021/ml2002955 ]